Parkinson’s disease: Is there a light at the end of a tunnel?
Author(s)
Andrei Surguchov*
ABSTRACT
Parkinson’s disease is the second most common neu- rodegenerative disorder after Alzheimer disease affecting 1% - 2% in people >60 years old and 3% - 4% in people >80.
Parkinson’s disease is the second most common neu- rodegenerative disorder after Alzheimer disease affecting 1% - 2% in people >60 years old and 3% - 4% in people >80.
Cite this paper
Surguchov, A. (2013) Parkinson’s disease: Is there a light at the end of a tunnel?. Advances in Parkinson's Disease, 2, 116-117. doi: 10.4236/apd.2013.24022.
Surguchov, A. (2013) Parkinson’s disease: Is there a light at the end of a tunnel?. Advances in Parkinson's Disease, 2, 116-117. doi: 10.4236/apd.2013.24022.
References
[1] Jankovic, J. (2008) Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79, 368-376. http://dx.doi.org/10.1136/jnnp.2007.131045 [2] Surguchov, A. (2008) Molecular and cellular biology of synucleins. International Review of Cell and Molecular Biology, 270, 225-317. http://dx.doi.org/10.1016/S1937-6448(08)01406-8 [3] Bartels, T., Choi, J.G. and Selkoe, D.J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature, 477, 107-110. http://dx.doi.org/10.1038/nature10324 [4] Burré, J., Vivona, S., Diao, J., Sharma, M., Brunger, A.T. and Südhof, T.C. (2013) Properties of native brain α-synuclein. Nature, 498, E4-E6 http://dx.doi.org/10.1038/nature12125 [5] Olanow, C.W. and Brundin, P. (2013) Parkinson’s disease and alpha synuclein: Is Parkinson’s disease a prion-like disorder? Movement Disorders, 28, 31-40. http://dx.doi.org/10.1002/mds.25373
[1] Jankovic, J. (2008) Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79, 368-376. http://dx.doi.org/10.1136/jnnp.2007.131045 [2] Surguchov, A. (2008) Molecular and cellular biology of synucleins. International Review of Cell and Molecular Biology, 270, 225-317. http://dx.doi.org/10.1016/S1937-6448(08)01406-8 [3] Bartels, T., Choi, J.G. and Selkoe, D.J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature, 477, 107-110. http://dx.doi.org/10.1038/nature10324 [4] Burré, J., Vivona, S., Diao, J., Sharma, M., Brunger, A.T. and Südhof, T.C. (2013) Properties of native brain α-synuclein. Nature, 498, E4-E6 http://dx.doi.org/10.1038/nature12125 [5] Olanow, C.W. and Brundin, P. (2013) Parkinson’s disease and alpha synuclein: Is Parkinson’s disease a prion-like disorder? Movement Disorders, 28, 31-40. http://dx.doi.org/10.1002/mds.25373